Skip to content

Author

Robert S. Rosenson

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Open access Nov 2026

In Vivo CRISPR Base Editing of ANGPTL3 for Durable Lipid Lowering.

A potential single-course treatment in which an infusion of guide RNA and mRNA encoding a CRISPR adenine base editor-encapsulated within a GalNAc-lipid nanoparticle-leads to durable, liver-selective inactivation of angiopoietin-like 3 (ANGPTL3), a known driver of increased LDL-C and triglyceride concentrations is descr...

Taiji Mizoguchi, Jamie E. Denizio, A. Chadwick et al. · 0 citations
Oct 2026

Association of Obesity With Intracranial Hemodynamic Alterations.

BACKGROUND Obesity increases the risk of stroke and cognitive decline, but its association with intracranial arterial hemodynamics remains unclear. We examined whether obesity score is associated with intracranial signal-intensity gradient, a time-of-flight magnetic resonance angiography-derived surrogate of arterial w...

Chan-Hyuk Lee, Seul-Ki Jeong, N. Park et al. · 0 citations
Jul 2026

Longer-Term Efficacy and Safety of Zodasiran in Patients with Mixed Hyperlipidaemia.

BACKGROUND Mixed hyperlipidaemia, characterized by elevated cholesterol and triglyceride levels, is associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). Angiopoietin-like protein 3 (ANGPTL3) regulates lipid metabolism through inhibition of lipoprotein and endothelial lipases. Loss-of-functi...

Robert S. Rosenson, Daniel Gaudet, Christie M. Ballantyne et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.